Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare AWP Rule: BIO Urges Careful Definition Of “Average Sales Price”

Executive Summary

CMS should follow the House Medicare bill's definition of "average sales price" if it chooses a competitive acquisition model to reform the AWP payment system, the Biotechnology Industry Organization suggests
Advertisement

Related Content

AWP Reform Reporting Requirements Need Clear Definition, PhRMA Says
AWP Reform Reporting Requirements Need Clear Definition, PhRMA Says
AWP Reform Must Wait For Congressional Study, Oncologists Say
AWP Reform Must Wait For Congressional Study, Oncologists Say
AWP Reform: Competitive Bidding Option Could Save The Most, CMS Says
AWP Reform: House Bill Offers Choice Of “Average Sales Price” Or Bids
AWP Reform: House Bill Offers Choice Of “Average Sales Price” Or Bids
Advertisement
UsernamePublicRestriction

Register

PS042617

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel